Our management team boasts a diverse and dynamic blend of expertise, bridging the realms of high tech, software sales, computer engineering, and peptide & protein biochemistry. This unique fusion of skills and experiences drives our innovative approach to developing cutting-edge peptide therapeutics. Get to know the passionate leaders who are steering NuvoBio towards a brighter future in biotechnology.
Meet the Team
Dr. Michael Cowpland
CEO, Co-Founder
Entrepreneur in software development.
Mike founded Corel Corp. in 1985. Over the next 15 years, he led Corel to become one of the world’s top software companies.
Dr. Valentina Lukinovic
Research Director
Experimental Chemist and Bioprocess Engineer
Dr. Lukinovic worked at the Cancer Research UK (Manchester), where she helped develop a drug for glioma treatment
Jim Stechyson
Business Advisor, Co-Founder
Technology Executive & Entrepreneur.
Business executive with experience in owning and operating both private & publicly traded companies.
Dr. Nour Nissan
Business Development
Protein Biochemist
Dr. Nissan joined NuvoBio following her tenure as a scientist at Agriculture Canada, bringing with her expertise in client engagement and regulatory affairs.
Dr. Kyle Biggar
Co-Founder
Peptide Biochemistry and Professor.
In 2016, Dr. Biggar was awarded the 2016 John C. Polanyi prize in Physiology and Medicine for his work in peptide therapeutics.
François Charih,
Research Scientist
Protein Biochemist and Computer Engineer
Francois' research is at the intersection between machine learning and protein biochemistry applied to peptide drug engineering.
Dr. James Green
Research Lead, Machine Learning
Computer Engineer and Professor
In 2005, Dr. Green co-founded Molecular Mining Corp. He later continued his work in the application of machine learning to biomedical informatics.
John Chapman
Accountant, Consultant